Northsea Therapeutics raised €36M in a Series B round in Jan 2020. The company is based in Naarden, Netherlands. Investors in the round: venBio Partners. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
